[Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects*; D002346:Carotid Sinus / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003655:Decerebrate State; D003714:Denervation; D003864:Depression, Chemical; D004558:Electric Stimulation; D004569:Electroencephalography; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D009474:Neurons / Q000187:drug effects; D010791:Phrenic Nerve / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012154:Reticular Formation / Q000187:drug effects; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014628:Vagotomy; D014666:Vasomotor System / Q000187:drug effects
D000959:Antihypertensive Agents; D007093:Imidazoles
Die zentralen Wirkungen des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorids.